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Bacterially produced secondary metabolites are
used as antibiotics, anticancer drugs, and for many
other medicinal applications. The mechanisms that
limit the production of these molecules in the
laboratory are not well understood, and this has
impeded the discovery of many important com-
pounds. We have identified small molecules that
remodel the yields of secondary metabolites in
many actinomycetes and show that one set of
these molecules does so by inhibiting fatty acid
biosynthesis. This demonstrates a particularly inti-
mate relationship between this primary metabolic
pathway and secondary metabolism and suggests
an approach to enhance the yields of metabolites
for discovery and biochemical characterization.
INTRODUCTION
The secondary metabolites produced by bacteria exhibit potent
biological activities and have been developed extensively for
antimicrobial, anticancer, and other vital therapeutic applica-
tions. Most of these molecules are polyketides and nonriboso-
mal peptides and are produced by biochemical pathways that
are encoded in discrete islands within the genome. The genes
encoded in these islands normally include all the metabolite-
specific biochemical steps; however, certain precursor mole-
cules and other resources are drawn from primary metabolism
(Martı´n and Liras, 2010; Olano et al., 2008).
An outstanding source of natural products and drug leads is
the actinobacteria. One of these, Streptomyces coelicolor, is
a superb model system for secondary metabolism due to its
production of pigmented secondary metabolites, including the
blue polyketide actinorhodin (Okamoto et al., 2009), and the
red prodiginines, undecylprodiginine and streptorubin B (Mo
et al., 2008). These molecules can be readily detected visually
and quantified spectrophotometrically.
Understanding the metabolic and regulatory mechanisms that
determine the yields of secondary metabolites from producer
organisms is important for the discovery and exploitation of
these molecules. A major outcome of genome sequencing has1020 Chemistry & Biology 19, 1020–1027, August 24, 2012 ª2012 Elbeen the discovery that each streptomycete chromosome
encodes many more secondary metabolites than can be de-
tected from routine laboratory culture (Bentley et al., 2002;
Nett et al., 2009). Efforts to enhance output have focused on
the engineering of strains to overexpress pathway-specific (Lau-
reti et al., 2011) and pleiotropic regulators (McKenzie et al., 2010)
of secondary metabolism and onmoving biosynthetic gene clus-
ters into engineered overproduction strains (Gomez-Escribano
and Bibb, 2011; Komatsu et al., 2010). These approaches have
been successful but are technically cumbersome and not ame-
nable to high throughput.
In this work we report the discovery of 19 small molecules that
remodel the secondary metabolite output of the streptomycetes.
We show that one set of these molecules targets fatty acid
biosynthesis, demonstrating that the relationship between pri-
mary and secondary metabolism is one limit on secondary
metabolite yields.
RESULTS
Small Molecule Probes of Secondary Metabolism
To identify small molecules that perturb secondary metabolism,
we screened theCanadianCompoundCollection of 30,569 small
molecules for their ability to alter the pigmentation ofS. coelicolor
colonies during growth on solid medium. The compounds were
screened at 10 mM in duplicate, colonies were examined daily
over a 10 day period (see Table S1 and Figure S1 available
online), and we focused in particular on hits that caused elevated
or precocious production of actinorhodin. A total of 112 primary
hits were identified, and of these, 19 compounds were selected
for follow-up on the basis of potency, reproducible behavior,
and the absence of pronounced antimicrobial activity.
Four of the 19 molecules, ARC2, ARC3, ARC4, and ARC5
(referred to as the ‘‘ARC2 series’’ for antibiotic-remodeling com-
pounds; Figure 1A), had similar structures and stimulated blue
pigmentation during growth on solid medium. Spectrophoto-
metric analysis of liquid cultures demonstrated that the ARC2
series also reduced yields of the prodiginines (Figure 1B). Using
LC-MS analysis, we found that ARC2 induced changes in the
production of two other S. coelicolor secondary metabolites.
Yields of the germicidins (Aoki et al., 2011) (germicidin B/C
183.107 [M+H]+ and germicidin A 197.125 [M+H]+) were en-
hanced 3-fold by ARC2 (Figure 1C); whereas yields of the
daptomycin-like calcium-dependent antibiotic (CDA) (1495.485
[M+H]+) (Hojati et al., 2002; Lewis et al., 2011) were reducedsevier Ltd All rights reserved
Figure 1. The ARC2 Series of Actinorhodin-
Inducing Molecules
(A) The structures of the ARC2 series and their
effect on blue pigmentation of S. coelicolor colo-
nies. Molecules were added at 0.39, 0.78, 1.56,
3.13, 6.25 12.5, 25, 50, and 100 mM to solid
medium along with S. coelicolor spores. The
DMSO solvent-only controls are indicated (D) and
in outer wells (1 and 11) of compound rows. The
plate was photographed following 3 days of
growth.
(B) Spectrophotometric analysis of prodiginine
yields in S. coelicolorM145 grown in the presence
of 25 mM ARC2 or with a solvent-only control
(DMSO) after 3 days of growth in liquid R5M ±SD.
(C) The effects of 10 mM ARC2 on germicidin
production (germicidin B/C 183.107 [M+H]+ and
germicidin A 197.125 [M+H]+) were assessed
using LC-MS analysis after 7 days of growth on
solid R5M.
(D) The production of CDA (1495.485 [M+H]+ for
CDA 4a) was assessed in the presence of DMSO
or 10 mM ARC2 using LC-MS after 7 days of
growth on solid R5M.
FabI-dependent fatty acid moieties of prodiginine
(B) and CDA (D) are shown in red.
See also Figure S1 and Table S1.
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cally remodel secondary metabolism in S. coelicolor.
These effects led us to investigate the action of ARC2 on
secondary metabolism in other bacteria. We added ARC2 to
cultures of Kutzneria sp. 744, S. pristinaespiralis ATCC 25486,
and Streptomyces peucetius 27952 and observed their small
molecule output using LC-MS (Figure 2). ARC2 enhanced yields
of desferrioxamine B and E (Barona-Go´mez et al., 2006) (561.362
and 601.360 [M+H]+, respectively) in S. pristinaespiralis (Fig-
ure 2A), doxorubicin (544.196 [M+H]+), baumycin (674.258
[M+H]+), and three unknown molecules (417.103 [M+H]+,
433.097 [M+H]+, and 615.356 [M+H]+) in S. peucetius (Lomov-
skaya et al., 1998) (Figure 2B), and an unknown metabolite
(252.175 [M+H]+) in Kutzneria (Figure 2C). Yields of some
secondary metabolites were unchanged: for example, ARC2
had no effect on yields of pristinamycin IIA (526.259 [M+H]+) in
S. pristinaespiralis (Mast et al., 2011). These data suggest that
the molecular target and mechanism of ARC2 are conserved in
these diverse actinomycetes.
Structural Determinants of ARC2 Activity
To gain further insight into the structural features of the ARC2
series, we generated a structure-activity library by sourcing
related commercial molecules (compounds 1–8) and by chemi-
cal synthesis (compounds 9–32) and exploring the capacity of
these molecules to alter secondary metabolism in S. coelicolor
(Figure 3A). Changes to the core structure (bottom-left panel in
Figure 3A) such as the removal of ring A (compound 6) or
replacement of the ether linkage between rings A and B with
a ketone (compound 5) eliminated the enhancement of blue
pigmentation. Insertion of an extra carbon between rings A andChemistry & Biology 19, 1020–B similarly abolished activity (compound 7). These data sug-
gested that the core shape of the molecules and rotational
freedom around the ether linkage are important for biological
activity.
The tails on ring B were the most variable feature (R4 and R5)
(top-right panel in Figure 3A); alterations introduced in the struc-
ture-activity analysis had similar variable effects on biological
activity. We investigated 13 substitutions at R4 and R5 in the
context of a functional ring A (a Cl at R1; see below) and found
that most variants exhibited relatively weak actinorhodin-stimu-
lating activity or were inactive. One variant that proved functional
was an acetamide group at R4 (Figure 3A, compound 16 in top-
left panel).
We similarly generated compounds having varied substitu-
tions on ring A in the context of an acetamide substitution at
position R4 of ring B (top-left panel in Figure 3A)—variation on
this ring had a greater influence on function. For example we
found that the absence of an electron-withdrawing group at R1
compromised biological activity (compound 18). The electron-
withdrawing group could not be moved to R2 or R3 without
reducing or eliminating activity (compounds 20, 21, and 22).
The nature of this electron-withdrawing group was also impor-
tant. For halogen substitutions, Br > Cl > F (compare compounds
9, 10, 16, and 17 in Figure 3A). Although halogens were most
active, other electron-withdrawing substitutions at R1 were
also tolerated, including N(CH3)2 and OCH3 (compare com-
pounds 11, 12, and 15 in top-left panel of Figure 3A). The only
substitution that did not agree with this rule was CH3, which
proved functional (compound 11).
This structure-activity analysis generated several molecules
that were active at lower concentrations than ARC2 (compounds1027, August 24, 2012 ª2012 Elsevier Ltd All rights reserved 1021
Figure 2. ARC2-Enhanced Yields of Secondary Metabolites
The effect of 10 mMARC2 on secondary metabolite output was assessed in (A)
S. pristinaespiralis, (B) S. peucetius, and (C) Kutzneria sp. 744 using LC-MS
analysis. All strains were grown for 7 days in the presence of either DMSO or
10 mM ARC2. Enhanced yields of desferrioxamine B and E (561.362 and
601.360 [M+H]+, respectively) in S. pristinaespiralis (A), doxorubicin (544.220
[M+H]+), baumycin (674.283 [M+H]+), and three unknown metabolites
(417.121, 433.115, 615.356 [M+H]+) in S. peucetius (B) and an unknown
metabolite (252.175 [M+H]+) in Kutzneria (C) were observed.
See also Figure S2.
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that the important features for activity were two benzene rings
joined by an ether linkage with, in most cases, an electron-with-
drawing group at the R1 position. As was the case with the initial
hits of the ARC2 series, we observed a correlation between
enhanced yields of g-actinorhodin and reduced yields of the pro-
diginines during liquid culture (Figure 3B). The conserved struc-
tural features of the active molecules and related phenotypic1022 Chemistry & Biology 19, 1020–1027, August 24, 2012 ª2012 Eleffects are consistent with a shared molecular mechanism of
action for the ARC2 series.
The ARC2 Series Target Fatty Acid Biosynthesis
Structural analysis of the ARC2 series suggested a possible
molecular target for the series. Several of the most active mole-
cules (e.g., compounds 16 and 17) were structurally similar to the
known antimicrobial agent triclosan, an inhibitor of fatty acid
synthesis (Figure 4A). Triclosan is a covalent inhibitor of the
FabI enoyl reductase, which catalyzes the final and rate-limiting
step in fatty acid biosynthesis (Bergler et al., 1996). We were
intrigued by this similarity because fatty acid biosynthesis shares
the precursors acetyl-CoA and malonyl-CoA with polyketide
biosynthesis. The ARC2 series might therefore shunt resources
from primary metabolism thereby enhancing the yields of some
polyketides. Indeed, of the five metabolites that we were able
to identify that were enhanced in yield by ARC2, four were
polyketides that depend on the cellular acyl-CoA pool: actino-
rhodin, doxorubicin, baumycin, and germicidin. Desferrioxamine
belongs to the nonpeptide hydroxymate siderophores, and at
least one step in its biosynthesis is dependent on acetyl-CoA
as well (Barona-Go´mez et al., 2004). Furthermore, the two
metabolites that were reduced in yields by ARC2, the prodigi-
nines and CDA, both contain fatty acid moieties (highlighted
with red on the structures in Figures 1B and 1D) that are gener-
ated via primary metabolism and require the enoyl reductase
activity of FabI (Hojati et al., 2002; Williamson et al., 2006).
FabI exhibits significant end-to-end sequence similarity and
is highly conserved in both its catalytic center and triclosan-
binding residues (see Figure S2) (Gago et al., 2011; Lu
and Tonge, 2008). This could be consistent with the broad spec-
trum of these molecules to influence secondary metabolism in
diverse organisms. We have addressed this hypothesis in
several ways.
First, we explored triclosan itself, finding that it exhibited
a potent antimicrobial effect on S. coelicolor growth in the
1–50 mM range where the ARC2 series influenced pigmentation
(the minimum inhibitory concentration was 3.13 mM). However,
when we reduced the triclosan concentration below the MIC,
we observed a clear stimulation of blue pigmentation (Fig-
ure 4B). This led us to synthesize three additional compounds
containing the 2-phenoxyphenol core of triclosan (compounds
33, 34, and 35) (Figure 4A), each of which has been shown
previously to inhibit FabI (Tipparaju et al., 2008). Compound 33
inhibited S. coelicolor growth with an MIC of 25 mM; compounds
34 and 35 were less-potent antimicrobials. Importantly, all three
triclosan/ARC2 chimeras stimulated blue pigmentation of
S. coelicolor colonies at concentrations that were subinhibitory
for growth (Figure 4B). The ability of triclosan and these known
FabI inhibitors to mimic the effects of ARC2 is consistent with
a shared mechanism involving the inhibition of FabI.
To test this hypothesis genetically, we created a S. coelicolor
strain that expressed the fabV gene from Pseudomonas aerugi-
nosa, which encodes a triclosan-resistant FabI paralog (Zhu
et al., 2010). The expression of this gene increased theMIC of tri-
closan against S. coelicolor from 3.13 to 100 mM but had no
effect on the MICs of antibiotics that target translation or DNA
replication (see Table S2). We compared the effects of ARC2,
ARC3, ARC4, and ARC5 and compounds 16, 17, 33, 34, andsevier Ltd All rights reserved
Figure 3. Effects of ARC2 and ARC2 Analogs on Actinorhodin and Prodiginine Biosynthesis
(A) Compounds 1–32 based on the ARC2 series were plated as a titration (0.39, 0.78, 1.56, 3.13, 6.25 12.5, 25, 50, and 100 mM) on solid MS agar in the presence of
S. coelicolorM145 spores. The DMSO solvent controls are indicated (D) and outer wells (1 and 11) of compound rows. Photographs were taken after 3 days of
growth with actinorhodin production denoted by the presence of a blue pigment.
(B) Titrations of increasing concentration of ARC2 and compounds 16 and 17 (1.56, 6.25, 12.5, 25 mM) were assessed for effects on actinorhodin and prodiginine
production and compared to a DMSO control after 3 days of growth in liquid R5M ± SD. Actinorhodin production is shown in blue and prodiginine in red.
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isogenic control (E) (Figure 4C). Consistent with the targeting of
fatty acid biosynthesis by these molecules, we found that the
expression of FabV impaired the effects of all of the molecules
on blue pigmentation. We observed residual actinorhodin-stim-
ulating activity at the highest concentrations of some com-
pounds (50 and 100 mM); however, there was a clear bypass
effect of fabV at lower concentrations. We then tested two otherChemistry & Biology 19, 1020–unrelated actinorhodin-inducing molecules from our primary
screen: ARC12 and 19. Neither of these is structurally related
to ARC2. The capacity of thesemolecules to stimulate actinorho-
din yields was not influenced by the fabV gene (Figure 4C).
We also explored the effect of fabV on the reduction of
prodiginine yields by the ARC2 series (see Figure S3) and found
that, indeed, this triclosan-resistant enoyl reductase restored
undecylprodiginine (394.287 [M+H]+) yields in the presence of1027, August 24, 2012 ª2012 Elsevier Ltd All rights reserved 1023
Figure 4. The ARC2 Series Acts through
Partial Inhibition of Fatty Acid Biosynthesis
(A) Comparison of the minimally activating struc-
ture (compound 16) with triclosan and three tri-
closan/ARC2series chimeras (compounds 33–35).
(B) The effects of these compounds on actino-
rhodin yields at 0.78, 1.56, 3.13, 6.25, 12.5, 25, 50,
and 100 mM. Solvent controls are indicated (D)
and in outer wells (1 and 10) of compound
rows. Actinorhodin yield was assessed by blue
pigmentation after 7 days of growth on solid
MS agar.
(C) ARC2–ARC5, compounds 16 and 17, the tri-
closan/ARC2 chimeras (compounds 33, 34, and
35), and triclosan were added at 0.78, 1.56, 3.13,
6.25 12.5, 25, 50, and 100 mM to cultures of
S. coelicolor expressing the triclosan-resistance
allele fabV (rows denoted V) or a control vector (E).
The DMSO solvent controls are in the outer wells
(wells one and ten). Similar analysis was applied to
ARC12 and ARC19, which are unrelated to the
putative or known FabI inhibitors.
See also Figure S3.
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ARC2 series that involves the inhibition of FabI.
Finally, we assessed the ability of the ARC2 series to inter-
fere with the biochemical activity of purified FabI in vitro. We
established an enzyme assay using E. coli FabI where the
consumption of NADH during the reduction of the substrate
crotonyl-CoA was measured (Liu et al., 2011). As expected,
we observed 100% inhibition of FabI with 0.01 mM triclosan.
Compound 33 inhibited FabI activity to completion at 1 mM;
compounds 34 and 35 inhibited 80% of the activity at
10 mM, consistent with their less-potent antimicrobial activities.
Confirming a capacity to impair FabI activity, 50 mM ARC2 and
compound 17 were able to inhibit FabI activity by 55% and
56%, respectively (Table 1). This work confirmed that the
ARC2 series inhibit the FabI enoyl reductase and that inhibi-
tion of this step is important for their effects on secondary
metabolism.
DISCUSSION
We have conducted a chemical screen against the life cycle of
S. coelicolor and identified 19 chemical probes of secondary
metabolism. We show that the ARC2 series is related to the anti-
biotic triclosan structurally and through their capacity to interfere
with FabI activity in vitro and in vivo. The expression of a triclo-
san-resistant enoyl reductase, FabV, confers triclosan resistance
and interferes with the effect of these molecules on actinorho-
din and prodiginine biosynthesis, demonstrating that impairing1024 Chemistry & Biology 19, 1020–1027, August 24, 2012 ª2012 Elsevier Ltd All rights resefatty acid biosynthesis remodels sec-
ondary metabolite yields. The reduction
in S. coelicolor’s two lipid-containing
secondary metabolites, prodiginine and
CDA, also correlates well with inhibition
of fatty acid biosynthesis because there
would be less lipids available for incorpo-
ration into these two metabolites.The relationship between polyketide and fatty acid bio-
synthesis appears to be a very intimate one. For example
most polyketide biosynthetic clusters, including those of
actinorhodin, doxorubicin, baumycin, and germicidin, do not
encode designated malonyl-CoA transferases for loading a
starter unit onto the polyketide acyl carrier protein. Instead,
they recruit the malonyl-CoA:ACP transacylase enzyme from
the fatty acid biosynthetic machinery for this purpose (Kop-
pisch and Khosla, 2003). The simplest interpretation of our
data, therefore, is that there is a balance between fatty acid
and polyketide biosynthesis in cells that helps set the upper
limit on polyketide yields. This balance could be manifested
at the level of precursor supply, malonyl-CoA:ACP transacylase
availability, or both. Inhibiting this primary metabolic pathway
therefore favors the polyketides and certain other metabolites
also sharing these precursors (e.g., desferrioxamine). Polyke-
tide biosynthesis is related to fatty acid biosynthesis bio-
chemically; however, most polyketide biosynthetic pathways
do not possess or require a designated enoyl reductase. This
includes the pathways for the ARC2-stimulated polyketides
that we have identified: actinorhodin, doxorubicin, baumycin,
and germicidin.
Partial inhibition, rather than complete inhibition, of fatty acid
biosynthesis is a critical feature of the most useful molecules
we have identified. Fatty acid biosynthesis is essential for via-
bility as demonstrated by the antimicrobial effect of triclosan
and at least two of the ARC2 analogs. Indeed, the most potent
inhibitors where characterized by a narrow concentration range,rved
Table 1. FabI Inhibition









Chemical Probes of Secondary Metabolismjust below their MIC for growth (e.g., 0.78–3.13 mM for triclosan,
and 3.13–12.5 mM for compound 33), at which they influenced
secondary metabolism. In contrast the weaker inhibitors ex-
hibited a broader concentration range at which they could influ-
ence secondary metabolism, and this range was not limited
by a strong antimicrobial effect at higher concentrations. For
example, for 16 and 17 we observed a stimulation of actinorho-
din biosynthesis over the two orders of magnitude between 0.78
and 100 mM.
Many strategies have been applied to the improvement in
yields of polyketides and other secondary metabolites, including
the overexpression of pathway-specific or pleiotropic regulators
(Martı´n and Liras, 2010). There have also been efforts to geneti-
cally enhance the availability of precursors (Olano et al., 2008; Ri-
gali et al., 2008). Although all of these approaches have met with
success, themajority requires genetic engineering of the starting
strains. One exception is ribosomal engineering, which only
requires the development of resistance to translation inhibitors
(Hosaka et al., 2009). These strategies, however, are more diffi-
cult to accomplish in high throughput and can be blocked by,
for example, the existence of restriction barriers to genetic
engineering. In contrast a strategy for secondary metabolite
screening that depends on small molecule perturbation is, in
principle, readily scalable to large numbers of strains using exist-
ing high-throughput technologies. We note that whereas we
observed relatively modest 2- to 5-fold enhancement in the
yields of actinorhodin, which is normally produced abundantly
during routine laboratory culture, the effect of ARC2 on some
other metabolites was more dramatic. Indeed, we observed
the induction of two unknown compounds in S. peucetius
(417.103 and 433.097 m/z) that could not be detected in the
absence of ARC2. This suggests that this strategy can be
applied to strains in the absence of genome sequence infor-
mation and that this could facilitate the discovery of new
metabolites.
The fact that perturbation of fatty acid biosynthesis can
enhance yields of some secondary metabolites suggests that it
would be worthwhile to investigate other pathways in primary
metabolism. For example the nature and importance of the links
between primary metabolism and the biosynthesis of aminogly-
coside, nonribosomal peptides, and other valuable secondary
metabolites are poorly understood. It is clear that the manipula-
tion of these pathways could have a significant impact on our
ability to access the full spectrum of secondary metabolites
in the many actinomycetes in academic and private sector
collections.Chemistry & Biology 19, 1020–SIGNIFICANCE
Secondary metabolites are vital to medicine, and strategies
to facilitate the identification and production of novelmetab-
olites are needed. Altering secondary metabolism through
small molecule addition has significant advantages because
it can be easily applied to any bacterial culture to alter
metabolite production. Because this approach does not
require genetic manipulation, it is readily scalable to high
throughput. We have identified 19 compounds that alter
the spectrum of metabolites produced by diverse strepto-
mycetes and show that one set of these molecules works
through the inhibition of fatty acid biosynthesis. In addition
to providing an approach to secondary metabolite identifi-
cation, this demonstrates an intimate link between a pri-
mary metabolic pathway, fatty acid synthesis, and many
secondary metabolic pathways. Presumably, the mecha-
nism by which this works involves shunting precursor mole-
cules from one pathway to the other.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Culture Conditions
Plasmid propagation and cloning were carried out in the E. coli strain DH5a.
E. coli strains were grown at 37C in Luria broth media. Antibiotic concentra-
tions were 100 mg/ml of ampicillin, 50 mg/ml of kanamycin, 34 mg/ml of chlor-
amphenicol, 25 mg/ml nalidixic acid, and 50 mg/ml of apramycin. All antibiotics
were purchased fromSigma-Aldrich. For introduction of plasmids into S. coeli-
color, plasmids were transformed into E. coli strain ET12567 containing the
pUZ8002 plasmid allowing for conjugal transfer of the plasmid (Flett et al.,
1997). S. coelicolor M145 was used for the high-throughput screen (HTS)
and subsequent follow-up, unless stated elsewhere. All actinomycete strains
were grown on solid R5M (100 g maltose, 10.12 g MgCl2 3 6H20, 0.5 g
K2SO4, 0.2 g Difco Casamino acids, 10 g yeast extract, 11.46 g TES, 4 ml trace
elements, 10 ml [0.5%] K2PO4, 4 ml [5 M] CaCl23 2H20, 15ml [20%] L-proline,
7 ml 1 M NaOH/l) or MS agar at 30C (Kieser et al., 2000). Kutzneria sp. 744,
S. pristinaespiralis ATCC 25486, and S. peucetius 27952 were used for LC-
MS analysis.
HTS for Small Molecules Altering S. coelicolor Growth
S. coelicolor M145 spores were dispensed at 20 cfu/well into 96-well
screening plates containing 200 ml R5M agar using a Biomex FX liquid handler
(Beckman Coulter). Twomicroliters of compounds was dispensed in duplicate
from 1 mM master plates into the screening plate to give a final screening
concentration of 10 mM of the Canadian Compound Collection of small mole-
cules (McMaster HTS facility). Outer columns were reserved for control mole-
cules with DMSO used as the normal growth control and thiostrepton (10 mM)
used as a growth inhibition control. Plates were shaken to distribute the
compounds evenly and then dried in a laminar flow hood for 2 hr. Phenotypes
were recorded over 10 days of growth at 30C.
Actinorhodin and Prodiginine Production
Liquid R5M cultures containing 23 107 cfu/ml of S. coelicolor were grown for
16 hr at 30C and subcultured into 5 ml aliquots containing either DMSO or
compounds of interest. DMSO concentration was kept constant at 0.1% for
liquid analysis. Actinorhodin and prodiginine production was assessed after
72 hr in the presence of 25 mMcompounds or DMSO, unless otherwise stated.
Both metabolites were measured spectrophotometrically as previously
described by Kieser et al. (2000). Briefly, 1 ml aliquots were centrifuged, and
supernatant was extracted with 1:1 chloroform:acidic methanol. The chloro-
form phase was read at 542 nm corresponding to g-actinorhodin. The pellet
was weighed and 1 ml of acidic methanol added; the supernatant was then
read at 530 nm, corresponding to prodiginines. Analysis of actinorhodin
production was also assessed visually on MS agar with DMSO concentrations
kept constant at 1%.1027, August 24, 2012 ª2012 Elsevier Ltd All rights reserved 1025
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R5M was inoculated with S. coelicolor, Kutzneria sp. 744, and
S. pristinaespiralis ATCC 25486, andMS agar was inoculatedwithS. peucetius
27952 in the presence of either DMSO or 10 mMARC2 and grown for 7 days at
30C. Strains were extracted in an equal volume of butanol, sonicated, and left
overnight. Extracts were filtered through Whatman paper and evaporated.
Extracts were resuspended in 1:1 CH3CN:H2O and subjected to LC-MS anal-
ysis. CDA was extracted after 7 days of growth on R5M as previously
described by Powell et al. (2007). LC-MS analysis was performed on an Agilent
1200 ‘‘RR’’ series LC system coupled to a Bruker micrOTOF II with an ESI ioni-
zation source. LC was carried out using a Phenomenex Kinetex C18 column
(50 3 2.1 mm, 2.6 mm, 100 A˚), H2O plus 0.1% formic acid (A), and CH3CN
plus 0.1% formic acid (B) as solvents, 40C column block, and the following
gradient: flow 0.2 ml/min, 0.5 min 5% B, 5–9 min 95% B, 10–15 min 5% B.
The MS conditions were set to a capillary voltage of 4.5kV for positive
mode, nebulizing gas pressure (N2) of 3 barr, dry gas flow rate (N2) of six
l/min, temperature at 200C, and a scan rate of 1 Hz.
Structure-Activity Library Construction and Analysis
Compounds 1–8 were purchased from Maybridge. Compounds 9–35 were
synthesized as described in the Supplemental Experimental Procedures.
Activity was assessed visually by the production of actinorhodin when spotted
as a titration (0.78, 1.56, 3.13, 6.25 12.5, 25, 50, 100 mM) on MS agar. Outer
columns contain DMSO only, and DMSO was kept constant at 1%.
FabV Complementation
FabV was PCR amplified from Pseudomonas aeruginosa PAO1 chromosomal
DNA and introduced into pSET152 containing the ErmE* promoter through the
use of the EcoRV and BamHI restriction sites. pSET152ermE*p and pSET152
ermE*pfabV were introduced into S. coelicolor by conjugal transfer. The
ability of FabV to compliment the antimicrobial activity of triclosan and other
antibiotics was assessed as a titration of compounds (0.39, 0.78, 1.56, 3.13,
6.25 12.5, 25, 50, 100 mM) on solid MS agar with outer wells containing
DMSO only. Prodiginine complementation was assessed through LC-MS
analysis. S. coelicolor M145 containing empty vector or FabV was grown for
7 days on solid MS agar in the presence of DMSO or ARC2 (1, 2.5, 5,
10 mM), extracted with butanol, dried, and resuspended in 1:1 CH3CN:H2O.
Samples were analyzed using the aforementioned LC-MS conditions.
FabI Enzyme Assay
The assay was conducted as previously described by Liu et al. (2011). Briefly,
10 mM of E. coli FabI (Sino Biological) in the presence of PIPES (30 mM), NaCl
(150 mM), NADH (250 mM), and crotonyl-CoA (200 mM) was assessed for its
ability to convert the crotonyl-CoA substrate. The rate of reaction was deter-
mined by the decrease in absorbance at 340 nm corresponding to NADH
consumption during crotonyl-CoA conversion by FabI. Crotonyl-CoA was
added last to initiate the reaction.
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